VOR
insider transactionsVor Biopharma Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-145.8K
0 buy · 145.8K sell
Net value · 365d
-$928.6K
$0 in · $928.6K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
3
0 buy · 145.8K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
31.0K sh
Own New
-
Grant·A
Director
$0
56.5K sh
Own New
-
Grant·A
Director
$0
57.2K sh
Own New
-
Grant·A
Director
$0
57.2K sh
Own New
-
Grant·A
Director
$0
57.2K sh
Own New
-
Grant·A
Director
$0
57.2K sh
Own New
-
Grant·A
Director
$0
56.3K sh
Own New
-
Sell·S
Alexander Cumbo KEY
President and CEO · 10b5-1
$96.9K
16.6K sh · $5.82
Own -7%
-
Exercise·M
Alexander Cumbo KEY
President and CEO · 10b5-1
$0
30.0K sh
Own +100%
-
Exercise·M
Alexander Cumbo KEY
President and CEO · 10b5-1
—
30.0K sh
Own +14%
-
Sell·S
Alexander Cumbo KEY
President and CEO · 10b5-1
$315.1K
48.9K sh · $6.44
Own -18%
-
Sell·S
Alexander Cumbo KEY
President and CEO · 10b5-1
$516.6K
80.3K sh · $6.44
Own -23%
-
Exercise·M
Alexander Cumbo KEY
President and CEO · 10b5-1
$0
100.4K sh
Own +50%
-
Exercise·M
Alexander Cumbo KEY
President and CEO · 10b5-1
—
100.4K sh
Own +40%
-
Grant·A
Alexander Cumbo KEY
President and CEO · 10b5-1
$0
169.4K sh
Own New
-
Grant·A
Alexander Cumbo KEY
President and CEO · 10b5-1
$0
254.9K sh
Own New
-
Grant·A
Alexander Cumbo KEY
President and CEO · 10b5-1
$0
509.9K sh
Own New
-
Exercise·M
Alexander Cumbo KEY
President and CEO · 10b5-1
$0
169.4K sh
Own New
-
Exercise·M
Alexander Cumbo KEY
President and CEO · 10b5-1
—
169.4K sh
Own +208%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Wouter Joustra | Grant A | 31.0K | $0 |
| Jun 11, 2026 | Fouad Namouni | Grant A | 56.5K | $0 |
| Jun 11, 2026 | Andrew David Levin | Grant A | 57.2K | $0 |
| Jun 11, 2026 | Erez Kalir | Grant A | 57.2K | $0 |
| Jun 11, 2026 | Wouter Joustra | Grant A | 57.2K | $0 |
| Jun 11, 2026 | Michel Detheux | Grant A | 57.2K | $0 |
| Jun 11, 2026 | Alexander Cumbo | Grant A | 56.3K | $0 |
| Feb 18, 2026 | Alexander Cumbo KEY 10b5-1 | Sell S | 16.6K | $96.9K |
| Feb 13, 2026 | Alexander Cumbo KEY 10b5-1 | Exercise M | 30.0K | $0 |
| Feb 13, 2026 | Alexander Cumbo KEY 10b5-1 | Exercise M | 30.0K | — |
| Feb 4, 2026 | Alexander Cumbo KEY 10b5-1 | Sell S | 48.9K | $315.1K |
| Feb 2, 2026 | Alexander Cumbo KEY 10b5-1 | Sell S | 80.3K | $516.6K |
| Jan 31, 2026 | Alexander Cumbo KEY 10b5-1 | Exercise M | 100.4K | $0 |
| Jan 31, 2026 | Alexander Cumbo KEY 10b5-1 | Exercise M | 100.4K | — |
| Jan 29, 2026 | Alexander Cumbo KEY 10b5-1 | Grant A | 169.4K | $0 |
| Jan 29, 2026 | Alexander Cumbo KEY 10b5-1 | Grant A | 254.9K | $0 |
| Jan 29, 2026 | Alexander Cumbo KEY 10b5-1 | Grant A | 509.9K | $0 |
| Jan 29, 2026 | Alexander Cumbo KEY 10b5-1 | Exercise M | 169.4K | $0 |
| Jan 29, 2026 | Alexander Cumbo KEY 10b5-1 | Exercise M | 169.4K | — |
About VOR insider trading
This page tracks insider transactions for Vor Biopharma Inc. (VOR) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.